Health-industry two-step: (1) Support bill with subsidies & cost controls, (2) Kill cost controls

Published



The drug industry firmly backed ObamaCare, and even ran ads supporting Senators and Congressmen attacked for passing it. The doctor lobby, hospital lobby, and device lobby signed onto the bill, too, albeit with less enthusiasm.

Of course, the bill was loaded up with subsidies that directly benefit health-care providers, and mandates that drive more money to the health sector. The biggest downside for providers: the Independent Payment Advisory Board (IPAB), which could impose cost controls on federal medical spending.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.